Table 2. The positive expression of Apc, IκBα, and NF-κB p65 protein is involved in clinicopathological characteristics of IA.
| Characteristics | Case | Apc | P-value | IκBα | P-value | ||
|---|---|---|---|---|---|---|---|
| Positive | Negative | Positive | Negative | ||||
| Age (years) | 0.411 | 0.606 | |||||
| <52 | 53 | 25 (47.17%) | 10 (18.87%) | 14 (26.42%) | 39 (73.58%) | ||
| ≥52 | 55 | 23 (41.82%) | 14 (25.45%) | 17 (30.91%) | 38 (69.09%) | ||
| Sex | 0.381 | 0.881 | |||||
| Male | 58 | 22 (37.93%) | 11 (18.97%) | 17 (29.31%) | 41 (70.69%) | ||
| Female | 50 | 26 (52.00%) | 13 (26.00%) | 14 (28.00%) | 36 (72.00%) | ||
| IA type | 0.365 | 0.819 | |||||
| Unruptured IA | 40 | 17 (42.50%) | 7 (17.50%) | 12 (30.00%) | 28 (70.00%) | ||
| Ruptured IA | 68 | 31 (45.59%) | 17 (25.00%) | 19 (27.94%) | 49 (72.06%) | ||
| IA diameter | 0.032 | 0.044 | |||||
| ≤5 mm | 44 | 26 (59.09%) | 14 (31.82%) | 15 (34.09%) | 29 (65.91%) | ||
| 5–13 mm | 40 | 18 (45.00%) | 9 (22.50%) | 14 (35.00%) | 26 (65.00%) | ||
| >13 mm | 24 | 4 (16.67%) | 1 (4.17%) | 2 (8.33%) | 22 (91.67%) | ||